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Open access under CC BActivation of the innate immune system is commonly accompanied by a set of behavioural, psychological
and physiological changes known as ‘sickness behaviour’. In animals, infection-related sickness symp-
toms are signiﬁcantly increased by exposure to psychosocial stress, suggesting that psychological and
immune stressors may operate through similar pathways to induce sickness. We used a double-blind,
randomised, placebo-controlled design to examine the effect of acute psychological stress on immune
and subjective mood responses to typhoid vaccination in 59 men. Volunteers were assigned to one of four
experimental conditions in which they were either injected with typhoid vaccine or saline placebo, and
then either rested or completed two challenging behavioural tasks. Typhoid vaccine induced a signiﬁcant
rise in participants’ serum levels of interleukin-6 (IL-6) and this response was signiﬁcantly larger in the
stress versus rest conditions. Negative mood increased immediately post-tasks, an effect also more pro-
nounced in the vaccine/stress condition. In the vaccine/stress group, participants with larger IL-6
responses had heightened systolic blood pressure responses to tasks and elevated post-stress salivary
levels of the noradrenaline metabolite 3-methoxy-phenyl glycol (MHPG) and cortisol. Our ﬁndings sug-
gest that, as seen in animals, psychological and immune stressors may act synergistically to promote
inﬂammation and sickness behaviour in humans.
 2008 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Chronic inﬂammatory and infectious diseases are commonly
accompaniedbya set of cognitive andaffective symptoms, including
confusion, fatigue, psychomotor retardation, impairedmemory, de-
creased motivation, anxiety and depression (Dantzer et al., 2007;
Evans et al., 2005). Until recently, these symptoms were considered
simply as a detrimental consequence of illness per se. However,
emerging evidence in humans and animals indicates that this ‘sick-
ness behaviour’ is in fact a highly organised adaptive response spe-
ciﬁcally designed to combat infection, and promote survival
(Dantzer et al., 2007;Hart, 1988). The inﬂammatory cytokines inter-
leukin-1b (IL-1b), interleukin-6 (IL-6) and tumour necrosis factor-a
(TNF-a), released from macrophages during the early innate im-
mune response, are thought to play a pivotal role in sickness behav-
iour by communicating peripheral inﬂammation to the brain
(Dantzer et al., 2008; Raison et al., 2006). Circulating cytokines can
signal the brain through a number of routes including activation of
vagal afferent ﬁbers projecting to the nucleus of the solitary tractY-NC-ND license.and higher viscerosensory centers, cytokine-speciﬁc transport mol-
ecules expressed on brain endothelium, and circumventricular or-
gans lacking the blood–brain barrier (Dantzer et al., 2008; Raison
et al., 2006). On reaching the brain, cytokine signals can be ampliﬁed
throughacentral cytokinenetwork thathasprofoundeffectsonneu-
rotransmitter metabolism, neuroendocrine function, synaptic plas-
ticity and behaviour (Hayley et al., 2005; Raison et al., 2006).
Circulating cytokines are elevated in patients with inﬂamma-
tory-related diseases such as rheumatoid arthritis, cardiovascular
disease and cancer, and have been shown to correlate with the
severity of depressive symptoms in these patients (Irwin and
Miller, 2007; Lesperance et al., 2004; Zautra et al., 2004). Cytokine
levels are also elevated in the circulation of adults with mild-mod-
erate as well as major depression (Irwin and Miller, 2007; Raison
et al., 2006). In rodents, peripheral injection with IL-1b or bacterial
lipopolysaccharide (LPS) (a potent stimulator of cytokine release)
reliably induces sickness behaviours including social withdrawal,
immobility and anorexia (Dantzer et al., 2007). Similarly, sick-
ness-related symptoms including depressed mood, fatigue and
psychomotor slowing are frequently observed in human cancer
and Hepatitis C patients receiving immunotherapy with IFN-a (a
potent inducer of IL-6) (Capuron and Miller, 2004).
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thought to occur solely through activation of the immune system
by a pathogen or inﬂammatory disease condition. However,
increasing evidence suggests that psychological stressors can
provoke sickness behaviour through a similar mechanism (Anis-
man and Merali, 2003; Simmons and Broderick, 2005). Psycho-
logical stress exacerbates a number of chronic inﬂammatory
conditions including asthma, arthritis and cardiovascular disease
(Black and Garbutt, 2002; Kemeny and Schedlowski, 2007) and
chronic stress is a key risk factor for anxiety and depressive ill-
ness (Kendler et al., 1999). Acute psychological stressors have
been shown to increase circulating levels of inﬂammatory cyto-
kines and negative mood symptoms in healthy humans (Steptoe
et al., 2007). Similarly, in animals, exposure to a novel environ-
ment, physical restraint and foot-shock stress increase both cir-
culating and central expression of inﬂammatory cytokines, and
induce sickness symptoms (Dantzer et al., 2007). Importantly, re-
cent evidence suggests that psychological (or heterotypic) stress-
ors can upregulate innate inﬂammatory and behavioural
responses to immune pathogens. In rats, prior exposure to ines-
capable tail shock induced a more rapid and larger inﬂammatory
cytokine response to peripheral LPS injection (Johnson et al.,
2002). Similarly, social disruption stress synergistically increased
inﬂammatory cytokine and sickness responses to peripheral
administration of LPS, IFNa or the viral analogue Poly I:C in
three separate studies of mice (Anisman et al., 2007; Gandhi
et al., 2007; Gibb et al., 2008). These ﬁndings lend further sup-
port to the idea that psychological and immune stressors operate
through similar biological pathways to induce sickness behav-
iour. However, so far no studies have investigated this phenom-
enon in humans.
We set out to address this issue by examining the effect of acute
psychological stress on immune and subjective mood responses to
typhoid (Salmonella typhi) vaccination in humans. Salmonella typhi
polysaccharide vaccine is a mild inﬂammatory stimulus, previously
shown by our group and others to increase circulating levels of
inﬂammatory cytokines and induce negative mood states in
healthy volunteers (Hingorani et al., 2000; Strike et al., 2004;
Wright et al., 2005). Unlike other experimental models of inﬂam-
mation, it does not provoke fever or feelings of malaise that could
potentially confound responses measured (Hingorani et al., 2000;
Strike et al., 2004; Wright et al., 2005). We hypothesised that acute
psychological stress would upregulate inﬂammatory cytokine re-
sponses to typhoid vaccination and that this mechanism would
provoke a larger increase in negative mood in volunteers subject
to both psychological and immune stress.2. Methods
2.1. Participants
Fifty-nine male student volunteers between 18 and 30 years
of age were recruited from University College London. Volun-
teers were screened by structured interview to ensure that they
were healthy, had no previous history of any relevant physical or
psychiatric illness, were taking no medication and were non-
smokers. Volunteers who had received typhoid vaccine in the
past 3 years or any other vaccine in the previous 6 months were
excluded. Participants were advised not to consume caffeinated
beverages or alcohol and to refrain from excessive exercise dur-
ing the 12 h prior to testing. They were also advised not to take
aspirin, ibuprofen, or antibiotics for 14 days prior to testing. All
participants gave their informed consent and the study was ap-
proved by the joint UCL/UCLH Committee on the Ethics of Hu-
man Research.2.2. General procedure
The study was performed in a double-blind, randomised, pla-
cebo-controlled manner. Participants were assessed individually
in the morning in a light- and temperature-controlled laboratory,
and all sessions commenced at 09h00. Measures of weight, height
and waist circumference were obtained using standardised meth-
ods and body fat mass was estimated using a Bodystat 1500 bio-
electrical impedance body composition analysis device (Bodystat,
Douglas, Isle of Man). A baseline blood sample (10 ml) was drawn
into a serum-separator Vacutainer tube (BD Vacutainer Systems,
Oxford, UK) by separate venipuncture using a 21-gauge butterﬂy
needle, then participants were randomly assigned to one of four
experimental conditions (15 vaccine and stress; 15 placebo and
stress; 14 vaccine and rest; 15 placebo and rest), by an investigator
who did not assist with participant testing at any stage. Injections
of either Salmonella typhi capsular polysaccharide vaccine
(0.025 mg in 0.5 ml, Typhim Vi, Aventis Pasteur MD) or control sal-
ine placebo (0.5 ml) were administered intramuscularly into the
non-dominant deltoid muscle at 09h45 by a trained nurse or phy-
sician, and participants rested for 30 min. At the end of the rest
period, participants either continued to rest or completed two
5 min challenging mental tasks. They were blinded to whether
they would rest or perform tasks until this time point. The ﬁrst task
was a computerized color-word interference (Stroop) task, involv-
ing the successive presentation of target color words printed in an
incongruous color. Participants were asked to press a computer key
that corresponded to the position at the bottom of the screen of the
name of the color in which the target word was printed. The sec-
ond task was a simulated public speaking exercise. Participants
were presented with a hypothetical scenario in which they had
been wrongly accused of shoplifting, and were instructed to give
a speech in their defense by addressing the camera directly in front
of them. After listening to a description of the scenario and instruc-
tions read out by the experimenter, participants were provided
with a written copy of the scenario and given two minutes to pre-
pare their speech. They were told that their speech would be video
recorded and later judged for efﬁcacy and ﬂuency. The experi-
menter remained in the room with the participant during delivery
of their speech, and instructed them when to start and stop. Fol-
lowing completion of the second task (10h45, 1 h post-vaccina-
tion), participants rested quietly for the remainder of the session.
They were asked to rate subjective feelings of stress on a 7-point
scale from 1 = low to 7 = high at baseline (towards the end of the
rest period), following each of the tasks and then at 30, 60 and
120 min post-task. Ratings of task difﬁculty, controllability and
involvement were also made after each task on 7-point scales,
and a second blood sample was drawn as described above, at
120 min post-tasks.
2.3. Psychological measures
Subjective ratings of mood and symptoms of illness were ob-
tained throughout the session using a modiﬁed 36-item version
of the Proﬁle of Mood States (POMS), as described previously
(McNair et al., 1981; Wright et al., 2005). Six high-loading items
were taken from the vigour, tension-anxiety, depression–dejection,
and confusion scales of the original POMS, and ﬁve items were ta-
ken from the fatigue scale. Four extra items were added to assess
symptoms associated with mild infection (fever, aching joints, nau-
sea, and headache). Participants were asked to rate how they felt at
that moment on a 5-point scale from 0 = not at all to 4 = extremely.
Ratings were obtained at baseline (towards the end of the rest per-
iod), immediately post-tasks, and at 30 min, 60 min and 120 min
post-tasks. Body temperature was also measured at these time
points using a sublingual digital thermometer. Total negative
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by summing all negative items (tension, depression, confusion and
fatigue). Overall mood scores could range from 0 to 96, with higher
scores indicating a more negative mood.
2.4. Cardiovascular and neuroendocrine measures
To investigate the biological pathways mediating the effects of
stress on inﬂammation and mood, measures of autonomic ner-
vous and hypothalamic-pituitary–adrenal (HPA) axes activity
were also included. Blood pressure (BP) and heart rate were mon-
itored throughout the session using a Portapres-2, a portable ver-
sion of the Finapres continuous BP monitoring device that shows
good reproducibility and accuracy in a range of settings (TNO-TPD
Biomedical Instrumentation, Amsterdam, Holland). Five-minute
recordings of BP and heart rate were made at baseline (towards
the end of the rest period), during each of the tasks, and then
at 25–30 min, 55–60 min and 115–120 min post-tasks. HPA axis
activity was assessed by salivary cortisol levels and catechol-
amine responses were indexed by salivary 3-methoxy-phenylgly-
col (MHPG), the major metabolite of norepinephrine (Reuster
et al., 2002). Salivary MHPG concentrations closely reﬂect both
central (cerebrospinal ﬂuid, CSF) and plasma MHPG levels and
are used as an indicator of noradrenergic activity (Reuster et al.,
2002; Yang et al., 1997). Saliva samples were collected using Sal-
ivettes (Sarstedt Inc., Leicester, UK) at baseline (towards the end
of the rest period), immediately after the second task, and at
15 min, 30 min, 60 min and 120 min post-tasks, then stored at
80 C prior to analysis. Salivary cortisol was measured by an en-
zyme-linked immunosorbent assay (ELISA) (SLV-2930, DRG Inter-
national, Inc., USA) at Kurume University, Japan. The limit of
detection of this assay was 0.53 ng/ml, with intra- and inter-assay
coefﬁcients of variation (CVs) of 2.61% and 3.63%, respectively.
Salivary MHPG was assessed using gas chromatography mass
spectrometry (Hitachi-M80B, Hitachi, Japan) at Kurume Univer-
sity, Japan, as described previously (Yajima et al., 2001). The limit
of detection of this assay was 0.55 ng/ml, with intra- and inter-as-
say CVs of 3.95% and 5.70%, respectively. All samples were ana-
lysed in duplicate.
2.5. Interleukin-6 measures
Whole blood samples (10 ml) were left upright to clot for
30 min, then centrifuged at 1250g for 10 min at room temperature.
Serum was removed, aliquoted and frozen at 80 C prior to anal-
ysis. Serum concentrations of IL-6 were assessed in duplicate sam-
ples by a high-sensitivity two-site ELISA from R&D Systems
(Oxford, UK). The limit of detection of this assay was 0.09 pg/ml,
with intra- and inter-assay CVs of 4.69% and 4.66%, respectively.Table 1
Sample characteristics and baseline measures
Vaccine/Stress (n = 15) Vaccine/Re
Age (years) 22.5 ± 3.2 22.5 ± 2.5
BMI (kg/m2) 22.3 ± 2.4 22.5 ± 3.4
Waist circumference (cm) 81.0 ± 6.9 80.0 ± 7.3
Body fat (%) 14.4 ± 4.0 14.7 ± 3.3
Systolic BP (mmHg) 115.6 ± 13.7 112.8 ± 14
Diastolic BP (mmHg) 69.6 ± 6.6 68.6 ± 8.1
Heart rate (bpm) 73.4 ± 11.8 71.5 ± 9.1
Cortisol (nmol/L) 5.19 ± 1.8 5.26 ± 1.8
Log MHPG (ng/mL) 1.99 ± 0.4 1.93 ± 0.5
Log IL-6 (pg/ml) 0.64 ± 0.3 0.64 ± 0.2
Total negative mood 11.06 ± 9.7 9.86 ± 4.4
Body temperature (C) 36.3 ± 1.1 36.2 ± 0.6
Somatic symptoms 0.40 ± 0.6 0.50 ± 1.22.6. Statistical analyses
The characteristics of participants in the four groups were com-
pared using analysis of variance for continuous measures, and v2
tests for categorical variables. Subjective stress and cardiovascular
responses were analysed using repeated measures analysis of var-
iance, with group (vaccine/placebo and stress/rest) as between-
person factors and trial (baseline, Stroop, Speech, recovery 1
(30 min), recovery 2 (60 min) and recovery 3 (120 min)) as the
within-person factor. The repeated measures analysis of cortisol
and MHPG involved six trials (baseline, task, and 15, 30, 60 and
120 min post-task), while the analysis of serum IL-6 only involved
baseline and 120 min post-task measures. The analyses of total
negative mood and vitality included vaccine and stress grouping
factors and ﬁve trials (baseline, immediately post-task, and 30,
60 and 120 min post-task). The Greenhouse–Geisser correction of
degrees of freedomwas applied when sphericity assumptions were
violated, but raw degrees of freedom are presented in the Results
section. Failed blood sampling or assay or equipment problems re-
sulted in some loss of data, so analyses were carried out with the
complete sample of 59 for subjective measures, 58 for cardiovascu-
lar variables and MHPG, 56 for cortisol, and 54 individuals for IL-6.
The distributions of serum IL-6 and MHPG were skewed, so were
log transformed before analysis, but the distribution of other vari-
ables was satisfactory. Post-hoc analyses were carried out using
Tukey’s least signiﬁcant difference (LSD) test.
3. Results
3.1. Participant characteristics
Sample characteristics and baseline measures are summarised
in Table 1. The four experimental groups did not differ signiﬁcantly
in age, anthropometric measures, or baseline levels of cardiovascu-
lar activity, neuroendocrine activity or serum interleukin-6. There
were also no signiﬁcant differences in mood scores between
groups. Participants’ body temperature was normal and none of
the participants reported any appreciable somatic symptoms.
3.2. Subjective, cardiovascular and neuroendocrine stress responses
There was a signiﬁcant stress by trial interaction in the analysis
of subjective stress ratings (F(5,26) = 47.3, p < 0.001). As can be
seen in Fig. 1, stress ratings increased in response to tasks, return-
ing to baseline levels during the post-task recovery period. There
was no difference in subjective stress responses to tasks between
vaccine and placebo conditions, and no effect of vaccine alone on
subjective stress ratings. Overall, the speech task was rated as
more difﬁcult than the Stroop task, with average ratings ofst (n = 14) Placebo/Stress (n = 15) Placebo/Rest (n = 15)
21.4 ± 3.0 22.9 ± 4.4
22.9 ± 1.9 23.1 ± 2.9
81.7 ± 4.7 84.0 ± 9.6
12.1 ± 3.1 13.2 ± 4.9
.1 119.0 ± 10.5 117.4 ± 10.7
68.4 ± 8.0 67.3 ± 6.2
72.1 ± 9.8 68.5 ± 8.5
6.57 ± 5.0 4.49 ± 1.2
1.89 ± 0.4 1.69 ± 0.4
0.71 ± 0.3 0.58 ± 0.3
10.53 ± 5.5 11.93 ± 5.2
36.4 ± 0.5 36.4 ± 0.5
0.33 ± 0.5 0.67 ± 0.9
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Fig. 1. Subjective stress ratings at baseline (Base), during each of the tasks (Stroop,
Speech) and at 30, 60 and 120 min post-tasks. Comparison of stress (solid lines) and
rest (dotted lines) conditions in participants receiving typhoid vaccine (circles) or
saline placebo (squares). Data are presented as means ± SEM.
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mance was rated as worse (means 2.57 ± 1.0 versus 4.33 ± 1.0,
F(1,28) = 33.8, p < 0.001). There was no difference between vaccine
and placebo conditions in subjective ratings of task difﬁculty or
performance.
As can be seen in Fig. 2 (A and B), systolic and diastolic BP in-
creased in response to behavioural tasks, returning towards base-
line during the post-task period. Repeated measures analysis of
variance showed signiﬁcant stress condition by trial interactions
for systolic BP (F(5,27) = 27.8, p < 0.001) and diastolic BP
(F(5,27) = 18.6, p < 0.001). There were no signiﬁcant differences in
the magnitude of systolic or diastolic BP responses to tasks be-
tween vaccine and placebo groups. Vaccine alone in the absence
of stress did not cause any increase in systolic or diastolic BP.
However, there was a small progressive increase in systolic and100
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Fig. 2. Systolic blood pressure (A), diastolic blood pressure (B), and heart rate (C) at base
120 min post-tasks. Comparison of stress (solid lines) and rest (dotted lines) conditions in
presented as means ± SEM.diastolic BP across trials in the two rest groups (F(5,13) = 2.93
and 7.99, respectively, p < 0.05). Analysis of heart rate also pro-
duced a signiﬁcant stress condition by trial interaction
(F(5,27) = 9.78, p < 0.001). Heart rate did not increase signiﬁcantly
during the Stroop task, but did rise in response to the Speech task
(Fig. 2C). Again there were no signiﬁcant differences in heart rate
responses between vaccine and placebo groups in either stress or
rest conditions.
The analysis of MHPG showed a main effect of trial
(F(5,27) = 2.51, p = 0.044) together with a signiﬁcant vaccine by
stress condition by trial interaction (p = 0.022). Separate analyses
indicated that the vaccine by trial interaction was signiﬁcant under
stress conditions (p = 0.028) but not rest conditions (p = 0.77). The
responses to stress in the vaccine and placebo conditions are
shown in Fig. 3. Participants in the vaccine/stress group showed
a mean increase of log MHPG of 0.19 (SD 0.24) ng/ml, compared
with a decrease of 0.20 (SD 0.39) ng/ml in the placebo/stress
group (p = 0.002). Cortisol showed a main effect of trial
(F(5,26) = 8.81, p < 0.001) due to a progressive reduction across tri-
als, with no difference between groups (data not shown).
3.3. Interleukin-6 responses
Analysis of serum IL-6 (which was logged before analysis)
showed a signiﬁcant vaccine by stress condition by trial interaction
(F(1,50) = 5.51, p = 0.023). IL-6 increased in response to the vac-
cine, but remained stable in the placebo conditions (Fig. 4). Post-
hoc tests using Tukey’s LSD conﬁrmed that the increase in IL-6
was signiﬁcantly greater in the vaccine/stress compared to vac-
cine/rest conditions (p = 0.04), with the rise averaging 0.90 (SD
0.28) and 0.59 (SD 0.43) in the two groups. Stress had no effect
on IL-6 in the absence of vaccine in this study.60
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Fig. 3. Salivary 3-methoxy-phenylglycol (MHPG) concentrations before (Base),
immediately following tasks (post-task) and at 15, 30, 60 and 120 min post-tasks.
Comparison of MHPG stress responses in participants receiving typhoid vaccine
(circles) or saline placebo (squares). MHPG was assessed using gas chromatography
mass spectrometry. Distributions of MHPG were skewed, so were log transformed
prior to analyses. Data are presented as log means ± SEM.
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Fig. 4. Serum interleukin-6 (IL-6) concentrations before (Base) and 120 min post-
tasks (120 min post-task). Comparison of stress (solid lines) and rest (dotted lines)
conditions in participants receiving typhoid vaccine (circles) or saline placebo
(squares). IL-6 was measured using a high-sensitivity two-site ELISA. Distributions
of IL-6 were skewed, so were log transformed prior to analyses. Data are presented
as log means ± SEM.
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Fig. 5. Total negative mood scores at baseline (Base), immediately following tasks
(post-task) and at 30, 60 and 120 min post-tasks. Comparison of stress (solid lines)
and rest (dotted lines) conditions in participants receiving typhoid vaccine (circles)
or saline placebo (squares). Data are presented as means ± SEM.
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
0 10 20 30 40 50 60 70 80
Systolic BP response (mmHg)
IL
-6
 c
ha
ng
e 
(p
g/
m
l)
Fig. 6. Scatter plot illustrating the relationship between systolic blood pressure
responses to the Speech task and changes in serum interleukin-6 (IL-6) levels, in the
vaccine/stress group.
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Analysis of total negative mood scores from the Proﬁle of Mood
States questionnaire showed a signiﬁcant stress condition by trial
interaction (F(4,22) = 6.25, p < .001), together with a vaccine by
stress condition by trial cubic effect (F(1,55) = 4.62, p = .036). These
effects are illustrated in Fig. 5. The stress condition by trial
interaction was due to an increase in negative mood immediately
post-tasks in the two stress groups. This increase was greater in
the vaccine/stress compared to placebo/stress groups. In post-hoc
analyses, the difference between vaccine and placebo responses
to stress was signiﬁcant (p = 0.05). Analysis of the individual POMS
scales making up total negative mood revealed signiﬁcant differ-
ences in acute responses for confusion (p = 0.01) and fatigue
(p = 0.003), but not for tension–anxiety, anger, or depression. Con-
fusion increased between baseline and post-task by 54.6% in the
vaccine/stress compared with 7.6% in the placebo/stress condition.
In the case of fatigue, there was an 8.6% rise in vaccine/stress and
33% reduction in the placebo/stress condition. There were no sig-
niﬁcant changes in somatic symptom ratings (fever, aching joints,
nausea and headache) or body temperature throughout the study,and no differences related to vaccine or stress conditions. Interleu-
kin-6 responses were not related to total negative mood ratings
immediately post-stress, in any of the groups. However, in the vac-
cine/stress group only, absolute levels of IL-6 at 2 h post-stress cor-
related with increases in fatigue at 2 h (r = 0.57, p = 0.027).
3.5. Relationship between cardiovascular and neuroendocrine
measures, cytokine responses and mood
There was no association between IL-6 and systolic blood pres-
sure at baseline. However, in the vaccine/stress condition, the IL-6
response correlated with systolic blood pressure responses to the
speech task (r = 0.65, p = .009) (Fig. 6). In the vaccine/stress group,
there was also a signiﬁcant association between absolute levels of
IL-6 at 2 h post-stress and systolic blood pressure at 2 h (r = 0.44,
p = .023). There was no signiﬁcant relationship between IL-6 mea-
sures and blood pressure responses in either of the placebo condi-
tions, and no association between IL-6 and measures of diastolic
blood pressure or heart rate.
In the vaccine/stress group only, the increase in IL-6 at 2 h was
associated with larger increases in MHPG between baseline and 1 h
post-stress, independently of baseline MHPG (r = 0.60, p = 0.023)
and with higher cortisol levels at 2 h post-stress (r = 0.70,
p = 0.005), independently of baseline cortisol. These effects were
not seen in any of the other three groups. There was no signiﬁcant
relationship between any of the cardiovascular or neuroendocrine
measures and mood ratings.
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Here we investigated whether acute psychological stress could
upregulate inﬂammatory cytokine and mood responses to a
peripheral immune stimulus, Salmonella typhi vaccine, in men. To
the best of our knowledge, this is the ﬁrst study to directly inves-
tigate a synergistic effect of psychological and immune stressors on
sickness behaviour in healthy humans. We predicted that acute
stress would enhance inﬂammatory cytokine responses to typhoid
vaccine in men and that this mechanism would lead to exagger-
ated infection-related sickness symptoms.
In line with our hypotheses, typhoid vaccine but not placebo in-
duced a signiﬁcant increase in participants’ serum levels of the
pro-inﬂammatory cytokine IL-6, and exposure to acute psycholog-
ical stress enhanced the IL-6 response to vaccine. This is in agree-
ment with previous reports in animals showing that acute
psychological (or heterotypic) stressors upregulate inﬂammatory
cytokine responses to immune pathogens (Anisman et al., 2007;
Gandhi et al., 2007; Gibb et al., 2008; Johnson et al., 2002). Some-
what unexpectedly, circulating IL-6 levels were not altered in the
placebo/stress group. Our group and others have previously shown
that acute psychological stress increases circulating levels of IL-6 in
healthy humans, reaching maximum levels at 2 h post-stress
(Steptoe et al., 2007). However, participants in this study were
all male, and there is evidence that women have larger IL-6 stress
responses than men (Steptoe et al., 2007).
As predicted, we also found that acute psychological stress in-
creased subjective ratings of negative mood in participants, and
this effect was particularly marked in the group who had received
typhoid vaccine versus placebo. The heightened mood response in
the presence of both psychological and immune stress is concor-
dant with previously reported synergistic effects of heterotypic
stressors on sickness responses in animals (Anisman et al., 2007;
Gandhi et al., 2007; Gibb et al., 2008; Simmons and Broderick,
2005). However, the kinetics of the mood response and the ob-
served lack of mood change in participants receiving typhoid vac-
cine alone were somewhat unexpected, based on our previous
research using the same experimental model. In two separate stud-
ies of healthy young men and women, we found that typhoid vac-
cine induced a sharp decline in mood between 1.5 and 3 h post-
vaccination, with mood levels continuing to fall until 6 h post-vac-
cine (Strike et al., 2004; Wright et al., 2005). In contrast, in the cur-
rent investigation, changes in negative mood occurred rapidly in
the vaccine/stress group, peaking immediately post-stress (1 h
post-vaccine) then returning to baseline levels by 30 min post-
stress, and mood was unaltered in the vaccine/rest comparison
group. Participants in the current study remained in the laboratory
throughout the entire testing session, whereas in previous studies
participants were free to return to their normal college schedule
between assessments, and it is conceivable that this might have af-
fected responses. Furthermore, animal evidence suggests that com-
bined exposure to two heterotypic stressors may alter the
dynamics of stress responses. Prior exposure to immobilisation
stress in rats signiﬁcantly increased circulating as well as central
levels of IL-1b 1 h following LPS injection, but did not potentiate
IL-1 b responses at later time points (Johnson et al., 2002). This is
consistent with a rapid, transient effect of psychological stress on
sickness responses to typhoid vaccine in humans.
Both circulating IL-6 levels and negative mood scores were
highest in the vaccine/stress group, suggesting that psychological
and immune stressors synergistically increased sickness behaviour
through up-regulating this cytokine. However, there was no signif-
icant relationship between serum IL-6 levels and negative mood
assessed immediately post-stress. Although IL-6 is a useful index
of inﬂammation, it acts as part of a network of several differentcytokines, and is induced primarily by interleukin-1b (IL-1b). It is
thus conceivable that IL-6 does not directly affect mood, but in-
stead reﬂects the production of another cytokine such as IL-1b that
modulates mood. Supporting this, peripheral administration of IL-
1b or bacterial LPS reliably induces a variety of sickness behaviours
in animals, whereas administration of IL-6 alone does not directly
induce sickness behaviour but rather potentiates the effects of IL-1
(Dantzer et al., 2007; Lenczowski et al., 1999). In line with the
kinetics of our observed mood response, IL-1b expression precedes
the IL-6 response to peripheral LPS (Dantzer et al., 2007), and
monocyte–macrophage levels of IL-1b increase rapidly (within
30 min) following exposure to acute psychological stress, whereas
stress-induced elevations in plasma IL-6 tend to be delayed (Bry-
don et al., 2004; Brydon et al., 2005; von Kanel et al., 2006). Unfor-
tunately we do not have data on serum levels of IL-1b since it acts
predominately in an autocrine/paracrine manner and is difﬁcult to
detect in healthy circulating blood (Dinarello, 1996). Notably, anal-
yses of the POMS subscales revealed that in the vaccine/stress
group only, post-stress IL-6 levels were associated with increases
in fatigue at 2 h (3 h post-vaccine). This corresponds to our previ-
ous results in women showing that IL-6 responses to typhoid vac-
cine correlated with a decline in mood 3 h following vaccination
(Wright et al., 2005), and suggests that IL-6 may play a more
important role in later mood responses.
A number of pathways have been implicated in stressor-induced
sickness responses. Psychological stress activates the sympathetic
nervous system (SNS) and hypothalamic–pituitary–adrenal (HPA)
axis, resulting in elevated blood pressure and heart rate and in-
creased circulating levels of the ‘stress hormones’ catecholamines
and glucocorticoids, which modulate inﬂammatory cytokine pro-
duction through binding to their respective receptors on peripheral
immune cells (Black and Garbutt, 2002). At the same time, periphe-
ral cytokines (IL-1, IL-6, TNFa) released during infection and/or psy-
chological stress, can feedback to the brain to exert potent effects on
neuroendocrine function and neurotransmitter metabolism (Dant-
zer et al., 2007). In animals, cytokines and/or stressor-induced
behavioural changes are associated with increased neuroendocrine
activity, as well as altered neurotransmitter turnover in brain re-
gions essential to the regulation of emotion, motor function and re-
ward (Anisman and Merali, 2003; Dunn, 2006). Notably, these
responses are signiﬁcantly more pronounced in animals concur-
rently exposed to psychological and immune stressors (Anisman
et al., 2007; Gandhi et al., 2007; Gibb et al., 2008; Merali et al.,
1997; Song et al., 1999), suggesting that these pathways maymedi-
ate the synergistic effects of heterotypic stressors on sickness. In hu-
mans, hyperactivity of neuroendocrine pathways and disrupted
neurotransmitter metabolism have been observed in clinically de-
pressed people (Hayley et al., 2005) and in patients undergoing
IFN-a therapy, where they correlate with development of speciﬁc
sickness symptoms (Capuron andMiller, 2004). In the current study,
there were no differences between vaccine and placebo conditions
in either cardiovascular or neuroendocrine responses to stress.
However, in the vaccine/stress group, participants with greater in-
creases in IL-6 had larger systolic blood pressure responses to the
Speech task, elevated post-stress salivary MHPG, and prolonged in-
creases in systolic BP following tasks, suggesting that hyperactivity
of the SNSmaymediate the heightened inﬂammatory andmood re-
sponses in this group. Supporting this idea, catecholamines increase
plasma levels of IL-6 in rodents, whereas in vivo blockade of the
autonomic nervous system or pre-treatment with b-adrenergic
receptor (b-AR) antagonists attenuates stress-induced increases in
plasma IL-6 (Johnson et al., 2005; Mohamed-Ali et al., 2001) and
prevents potentiation of LPS-inducedmacrophage cytokine produc-
tion by foot-shock stress in animals (Broug-Holub et al., 1998).
Whether b-AR antagonists would prevent the synergistic effects of
L. Brydon et al. / Brain, Behavior, and Immunity 23 (2009) 217–224 223typhoid vaccine and psychological stress observed in our study re-
mains to be investigated.
Stress-induced enhancement of the innate immune response to
infection and consequent sickness symptoms can be thought of as
an evolutionary adaptive mechanism, designed to conserve energy
and combat infection during times of adversity such as wounding
due to a predator-prey encounter (Hart, 1988). However, in the
context of ongoing inﬂammation, these effects may become detri-
mental. In humans, stressful life events have been linked to the on-
set and exacerbation of illness symptoms in a number of chronic
inﬂammatory conditions where cytokines are elevated, including
rheumatoid arthritis, cardiovascular disease, multiple sclerosis,
asthma and psoriasis (Black and Garbutt, 2002; Kemeny and
Schedlowski, 2007; Perry et al., 2007). Notably, depressive symp-
toms are prevalent in many of these conditions, and are predictive
of increased disease morbidity and mortality (Evans et al., 2005; Ir-
win and Miller, 2007).
This investigation was carried out in a sample of healthy male
university students, and results may not generalise to other popu-
lations. Blood was sampled at a single post-stress time point (2 h),
making it difﬁcult to determine when the peak cytokine response
occurred, and a more detailed cytokine proﬁle including earlier
time points would have been useful. Cytokine and mood responses
were relatively small. However, this is consistent with the fact that
Salmonella typhi vaccine is a mild inﬂammatory stimulus compared
to other endotoxin models (Krabbe et al., 2005; Wright et al.,
2005). The correlation between IL-6 and systolic BP responses
was dependent on extreme responders, so corroboration in a larger
data set would be desirable. We also did not measure peripheral
neurotransmitter levels and it will be important to carry out addi-
tional studies to investigate the potential contribution of these
pathways, as well as the mechanisms underlying differences be-
tween our current ﬁndings and previous observations using the
same inﬂammatory model.
Taken together, our results provide added insight into the bio-
logical mechanisms through which psychological and immune
stressors interact to exacerbate sickness behaviour in humans. Im-
proved understanding of these mechanisms may inform the devel-
opment of new psychopharmacological interventions to combat
the depressive symptoms that commonly accompany inﬂamma-
tory disease, thereby improving patient outcomes.
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